Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2022

Open Access 01-12-2022 | Mood Disorders | Study protocol

Elucidating treatment targets and mediators within a confirmatory efficacy trial: study protocol for a randomized controlled trial of cognitive-behavioral therapy vs. light therapy for winter depression

Authors: Kelly J. Rohan, Peter L. Franzen, Kathryn A. Roeckelin, Greg J. Siegle, David J. Kolko, Teodor T. Postolache, Pamela M. Vacek

Published in: Trials | Issue 1/2022

Login to get access

Abstract

Background

This study is a confirmatory efficacy trial of two treatments for winter seasonal affective disorder (SAD): SAD-tailored group cognitive-behavioral therapy (CBT-SAD) and light therapy (LT). In our previous efficacy trial, post-treatment outcomes for CBT-SAD and LT were very similar, but CBT-SAD was associated with fewer depression recurrences two winters later than LT (27.3% in CBT-SAD vs. 45.6% in LT). CBT-SAD engaged and altered a specific mechanism of action, seasonal beliefs, which mediated CBT-SAD’s acute antidepressant effects and CBT-SAD’s enduring benefit over LT. Seasonal beliefs are theoretically distinct from LT’s assumed target and mechanism: correction of circadian phase. This study applies the experimental therapeutics approach to determine how each treatment works when it is effective and to identify the best candidates for each. Biomarkers of LT’s target and effect include circadian phase angle difference and the post-illumination pupil response. Biomarkers of CBT-SAD’s target and effect include decreased pupillary and sustained frontal gamma-band EEG responses to seasonal words, which are hypothesized as biomarkers of seasonal beliefs, reflecting less engagement with seasonal stimuli following CBT-SAD. In addition to determining change mechanisms, this study tests the efficacy of a “switch” decision rule upon recurrence to inform clinical decision-making in practice.

Methods

Adults with SAD (target N = 160) will be randomzied to 6-weeks of CBT-SAD or LT in winter 1; followed in winter 2; and, if a depression recurrence occurs, offered cross-over into the alternate treatment (i.e., switch from LT➔CBT-SAD or CBT-SAD➔LT). All subjects will be followed in winter 3. Biomarker assessments occur at pre-, mid-, and post-treatment in winter 1, at winter 2 follow-up (and again at mid-/post-treatment for those crossed-over), and at winter 3 follow-up. Primary efficacy analyses will test superiority of CBT-SAD over LT on depression recurrence status (the primary outcome). Mediation analyses will use parallel process latent growth curve modeling.

Discussion

Consistent with the National Institute of Mental Health’s priorities for demonstrating target engagement at the level of Research Domain Criteria-relevant biomarkers, this work aims to confirm the targets and mechanisms of LT and CBT-SAD to maximize the impact of future dissemination efforts.

Trial registration

ClinicalTrials.​gov identifier: NCT03691792. Registered on October 2, 2018. 
Literature
1.
Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, et al. Seasonal affective disorder: a description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry. 1984;41(1).
2.
Blazer DG, Kessler RC, Swartz MS. Epidemiology of recurrent major and minor depression with a seasonal pattern. The national comorbidity survey. Br J Psychiatry. 1998;172(FEB.).
3.
Magnusson A, Boivin D. Seasonal affective disorder: an overview. Chronobiol Int. 2003;20.
4.
Rosen LN, Targum SD, Terman M, Bryant MJ, Hoffman H, Kasper SF, et al. Prevalence of seasonal affective disorder at four latitudes. Psychiatry Res. 1990;31(2).
5.
Booker JM, Hellekson CJ. Prevalence of seasonal affective disorder in Alaska. Am J Psychiatry. 1992;149(9).
6.
Magnusson A. An overview of epidemiological studies on seasonal affective disorder. Acta Psychiatr Scand. 2000;101.
7.
Hardin TA, Wehr TA, Brewerton T, Kasper S, Berrettini W, Rabkin J, et al. Evaluation of seasonality in six clinical populations and two normal populations. J Psychiatr Res. 1991;25(3).
8.
Rohan KJ, Sigmon ST. Seasonal mood patterns in a northeastern college sample. J Affect Disord. 2000;59(2).
9.
Modell JG, Rosenthal NE, Harriett AE, Krishen A, Asgharian A, Foster VJ, et al. Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL. Biol Psychiatry. 2005;58(8).
10.
Schlager D, Froom J, Jaffe A. Winter depression and functional impairment among ambulatory primary care patients. Compr Psychiatry. 1995;36(1).
11.
Rohan KJ. Coping with the seasons: a cognitive-behavioral approach to seasonal affective disorder: therapist guide. New York: Oxford University Press; 2008.
12.
Golden RN, Gaynes BN, Ekstrom RD, Hamer RM, Jacobsen FM, Suppes T, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry. 2005;162.
13.
Rohan KJ, Mahon JN, Evans M, Ho SY, Meyerhoff J, Postolache TT, et al. Randomized trial of cognitive-behavioral therapy versus light therapy for seasonal affective disorder: acute outcomes. Am J Psychiatry. 2015;172(9):862–9.CrossRef
14.
Rohan KJ, Meyerhoff J, Ho S-Y, Evans M, Postolache TT, Vacek PM. Outcomes one and two winters following cognitive-behavioral therapy or light therapy for seasonal affective disorder. Am J Psychiatry. 2016 Feb;173(3):244–51.CrossRef
15.
Terman M, Terman JS, Quitkin FM, McGrath PJ, Stewart JW, Rafferty B. Light therapy for seasonal affective disorder. A review of efficacy. Vol. 2, Neuropsychopharmacology. 1989.
16.
Lam RW, Levitt AJ, Blashko C, Terman M. Canadian Consensus Guidelines for the Treatment of Seasonal Affective Disorder Edited by On Behalf of the Canadian Consensus Group on SAD. 1999;
17.
Pandi-Perumal SR, Partonen T. Seasonal affective disorder: practice and research. 2010;352.
18.
Schwartz PJ, Brown C, Wehr TA, Rosenthal NE. Winter seasonal affective disorder: a follow-up study of the first 59 patients of the National Institute of Mental Health seasonal studies program. Am J Psychiatry. 1996;153(8).
19.
Avery DH, Dahl K, Savage M v, Brengelmann GL, Larsen LH, Kenny MA, et al. Circadian temperature and cortisol rhythms during a constant routine are phase-delayed in hypersomnic winter depression. Biol Psychiatry. 1997;41(11).
20.
Lewy AJ, Lefler BJ, Emens JS, Bauer VK. The circadian basis of winter depression. Proceedings of the National Academy of Sciences of the United States of America. 2006;103(19).
21.
Lewy AJ, Rough JN, Songer JB, Mishra N, Yuhas K, Emens JS. The phase shift hypothesis for the circadian component of winter depression. Dialogues Clin Neurosci. 2007;9.
22.
Lewy AJ, Bauer VK, Cutler NL, Sack RL, Ahmed S, Thomas KH, et al. Morning vs evening light treatment of patients with winter depression. Arch Gen Psychiatry. 1998;55(10).
23.
Eastman CI, Young MA, Fogg LF, Liu L, Meaden PM. Bright light treatment of winter depression: a placebo-controlled trial. Arch Gen Psychiatry. 1998;55(10).
24.
Terman JS, Terman M, Lo ES, Cooper TB. Circadian time of morning light administration and therapeutic response in winter depression. Arch Gen Psychiatry. 2001;58(1).
25.
Terman M, Terman JS, Ross DC. A controlled trial of timed bright light and negative air ionization for treatment of winter depression. Arch Gen Psychiatry. 1998;55(10).
26.
Roecklein K, Wong P, Ernecoff N, Miller M, Donofry S, Kamarck M, et al. The post illumination pupil response is reduced in seasonal affective disorder. Psychiatry Res. 2013;210(1).
27.
Wehr TA, Duncan WC, Sher L, Aeschbach D, Schwartz PJ, Turner EH, et al. A circadian signal of change of season in patients with seasonal affective disorder. Arch Gen Psychiatry. 2001;58(12).
28.
Neumeister A, Turner EH, Matthews JR, Postolache TT, Barnett RL, Rauh M, et al. Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. Arch Gen Psychiatry. 1998;55(6).
29.
Roecklein KA, Wong PM, Franzen PL, Hasler BP, Wood-Vasey WM, Nimgaonkar VL, et al. Melanopsin gene variations interact with season to predict sleep onset and chronotype. Chronobiol Int. 2012;29(8).
30.
Gamlin PDR, McDougal DH, Pokorny J, Smith VC, Yau KW, Dacey DM. Human and macaque pupil responses driven by melanopsin-containing retinal ganglion cells. Vision Res. 2007;47(7).
31.
Roecklein KA, Franzen PL, Wescott DL, Hasler BP, Miller MA, Donofry SD, et al. Melanopsin-driven pupil response in summer and winter in unipolar seasonal affective disorder. J Affect Disord. 2021 Aug;1(291):93–101.CrossRef
32.
Rohan KJ, Meyerhoff J, Ho SY, Roecklein KA, Nillni YI, Hillhouse JJ, et al. A measure of cognitions specific to seasonal depression: development and validation of the seasonal beliefs questionnaire. Psychol Assessment. 2019;31(7).
33.
Rohan KJ, Meyerhoff J, Roecklein KA, DeSarno MJ, Vacek PM. Predictive validity of the Seasonal Beliefs Questionnaire for discriminating between seasonal and nonseasonal major depressive disorder. Psychol Assessment. 2021;33(4).
34.
Rohan KJ, Burt KB, Camuso J, Perez J, Meyerhoff J. Applying experimental therapeutics to examine cognitive and chronological vulnerabilities as mediators of acute outcomes in cognitive-behavioral therapy and light therapy for winter depression. J Consult Clin Psychol. 2020;88(8).
35.
Rohan KJ, Burt KB, Norton RJ, Perez J, Iyiewuare P, Terman JM. Change in seasonal beliefs mediates the durability advantage of cognitive-behavioral therapy over light therapy for winter depression.
36.
Siegle GJ, Steinhauer SR, Friedman ES, Thompson WS, Thase ME. Remission prognosis for cognitive therapy for recurrent depression using the pupil: utility and neural correlates. Biol Psychiatry. 2011;69(8).
37.
Siegle GJ, Steinhauer SR, Stenger VA, Konecky R, Carter CS. Use of concurrent pupil dilation assessment to inform interpretation and analysis of fMRI data. NeuroImage. 2003;20(1).
38.
Siegle GJ, Condray R, Thase ME, Keshavan M, Steinhauer SR. Sustained gamma-band EEG following negative words in depression and schizophrenia. Int J Psychophysiol. 2010;75(2).
39.
Ghadirian AM, Murphy BEP, Gendron MJ. Efficacy of light versus tryptophan therapy in seasonal affective disorder. J Affect Disord. 1998;50(1).
40.
Lam RW, Levitan RD, Tam EM, Yatham LN, Lamoureux S, Zis AP. L-tryptophan augmentation of light therapy in patients with seasonal affective disorder. Can J Psychiatry. 1997;42(3).
41.
American Psychiatric Association. Structured Clinical Interview for DSM-5 Axis I Disorders—Research Version (SCID-5-RV). Washington, DC; 2014.
42.
Williams JB, Link MJ, Rosenthal NE, Amira L, Terman M. Structured Interview Guide for the Hamilton Depression Rating Scale—Seasonal Affective Disorder Version (SIGH-SAD). New York: New York State Psychiatric Institute; 1992.
43.
Rohan KJ, Roecklein KA, Lindsey KT, Johnson LG, Lippy RD, Lacy TJ, et al. A randomized controlled trial of cognitive-behavioral therapy, light therapy, and their combination for seasonal affective disorder. J Consult Clin Psychol. 2007;75(3).
44.
Rohan KJ, Roecklein KA, Lacy TJ, Vacek PM. Winter depression recurrence one year after cognitive-behavioral therapy, light therapy, or combination treatment. Behavior Therapy. 2009;40(3).
45.
Herschell AD, Kolko DJ, Baumann BL, Davis AC. The role of therapist training in the implementation of psychosocial treatments: a review and critique with recommendations. Clin Psychol Rev. 2010;30.
46.
Levitt AJ, Joffe RT, Moul DE, Lam RW, Teicher MH, Lebegue B, et al. Side effects of light therapy in seasonal affective disorder. Am J Psychiatry. 1993;150(4).
47.
Khalsa SBS, Jewett ME, Cajochen C, Czeisler CA. A phase response curve to single bright light pulses in human subjects. J Physiol. 2003;549.
48.
Burgess HJ, Fogg LF, Young MA, Eastman CI. Bright light therapy for winter depression - is phase advancing beneficial? Chronobiol Int. 2004;21(4–5).
49.
Burns DD, Spangler DL. Does psychotherapy homework lead to improvements in depression in cognitive-behavioral therapy or does improvement lead to increased homework compliance? J Consult Clin Psychol. 2000;68(1).
50.
Hollon SD, Evans M, Elkin E, Lowery HA. System for rating therapies for depression. CA: Los Angeles; 1984.
51.
System for Psychotherapy Ratings Project Staff. Final report: system for rating psychotherapy audiotapes. 1984.
52.
Beck AT, Steer RA, Brown GK. Beck Depression Inventory—2nd edition manual. San Antonio, TX: The Psychological Corporation; 1996.
53.
Beck AT, Steer RA. Beck Anxiety Inventory manual. San Antonio, TX: Psychological Corporation; 1993.
54.
Monk TH, Reynolds CF, Kupfer DJ, Buysse DJ, Coble PA, Hayes AJ, et al. The Pittsburgh Sleep Diary. J Sleep Res. 1994;3(2).
55.
Weissman AN, Beck AT. Development and validation of the Dysfunctional Attitude Scale: a preliminary investigation. Report: ED167619. 33pp. Mar 1978. 1978.
56.
Kanter JW, Mulick PS, Busch AM, Berlin KS, Martell CR. The Behavioral Activation for Depression Scale (BADS): psychometric properties and factor structure. J Psychopathol Behav Assessment. 2007;29(3).
57.
Smith CS, Reilly C, Midkiff K. Evaluation of three circadian rhythm questionnaires with suggestions for an improved measure of morningness. J Appl Psychol. 1989;74(5).
58.
Borkovec TD, Nau SD. Credibility of analogue therapy rationales. J Behav Therapy Exp Psychiatry. 1972;3(4).
59.
Millon T, Millon C, Grossman S. Millon clinical multiaxial inventory - IV manual. 4th ed. Bloomington: NCS Pearson, Inc.; 2015.
60.
Endicott J, Nee J, Harrison W, Blumenthal R. Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bulletin. 1993.
61.
Sheehan D, v. The anxiety disease. New York: Charles Scribner and Sons; 1983.
62.
Terman M, Terman JS, Rafferty B. Experimental design and measures of success in the treatment of winter depression by bright light. Psychopharmacol Bulletin. 1990.
63.
Rohan KJ, Rough JN, Evans M, Ho SY, Meyerhoff J, Roberts LM, et al. A protocol for the Hamilton Rating Scale for Depression: item scoring rules, rater training, and outcome accuracy with data on its application in a clinical trial. J Affect Disord. 2016;200.
64.
Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey: reliability and validity in a patient population. Medical Care. 1988;26(7).
65.
Pokorny J, Smith VC, Lutze M. Aging of the human lens. Appl Optics. 1987;26(8).
66.
Park JC, Moura AL, Raza AS, Rhee DW, Kardon RH, Hood DC. Toward a clinical protocol for assessing rod, cone, and melanopsin contributions to the human pupil response. Invest Ophthalmol Vis Sci. 2011;52(9).
67.
Zele AJ, Feigl B, Smith SS, Markwell EL. The circadian response of intrinsically photosensitive retinal ganglion cells. PLoS ONE. 2011;6(3):e17860.CrossRef
68.
69.
Bradley MM, Lang PJ. Affective norms for English words (ANEW): instruction manual and affective ratings. Technical Report C-1. 1999.
70.
Siegle GJ, Ichikawa N, Steinhauer S. Blink before and after you think: blinks occur prior to and following cognitive load indexed by pupillary responses. Psychophysiology. 2008;45(5).
71.
Kerr M, Siegle GJ, Orsini J. Voluntary arousing negative experiences (VANE): Why we like to be scared. Emotion. 2019;19(4).
72.
Cheong JW, MacKinnon DP, Khoo ST. Investigation of mediational processes using parallel process latent growth curve modeling. Struct Equ Modeling. 2003;10(2).
73.
Preacher KJ. Advances in mediation analysis: a survey and synthesis of new developments. Annu Rev Psychol. 2015;66.
74.
von Soest T, Hagtvet KA. Mediation analysis in a latent growth curve modeling framework. Struct Equ Modeling. 2011;18(2).
75.
Preacher KJ, Kelley K. Effect size measures for mediation models: quantitative strategies for communicating indirect effects. Psychological Methods. 2011;16(2).
76.
Muthén LK, Muthén BO. Mplus. CA: Los Angeles; 2015.
Metadata
Title
Elucidating treatment targets and mediators within a confirmatory efficacy trial: study protocol for a randomized controlled trial of cognitive-behavioral therapy vs. light therapy for winter depression
Authors
Kelly J. Rohan
Peter L. Franzen
Kathryn A. Roeckelin
Greg J. Siegle
David J. Kolko
Teodor T. Postolache
Pamela M. Vacek
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-022-06330-9

Other articles of this Issue 1/2022

Trials 1/2022 Go to the issue

Study protocol

Effect of first dorsal interosseous strengthening on clinical outcomes in patients with thumb osteoarthritis: a study protocol for a randomized controlled clinical trial

Study protocol

Awake prone positioning in nonintubated spontaneous breathing ICU patients with acute hypoxemic respiratory failure (PRONELIFE)—protocol for a randomized clinical trial

Study protocol

Effectiveness of a high-intensive trauma-focused, family-based therapy for youth exposed to family violence: study protocol for a randomized controlled trial

Research

Developing a theoretically informed education programme within the context of a complex implementation strategy in UK primary care: an exemplar from the IMP2ART trial

Study protocol

Functional imaging-guided carbon ion irradiation with simultaneous integrated boost for localized prostate cancer: study protocol for a phase II randomized controlled clinical trial

Study protocol

Identifying Child Anxiety Through Schools-identification to intervention (iCATS-i2i): protocol for a cluster randomised controlled trial to compare screening, feedback and intervention for child anxiety problems to usual school practice